سعر ليليبل 5مجم 20 قرص قابل المضغ 2024

Montelukast 5 mg chewable tablets, pack of 20 (2 strips).

• Prophylaxis and chronic treatment of asthma in children 6 to 14 years (5 mg chewable tablet).Population: Children 6-14 yearsDailyMed (U.S. National Library of Medicine)
• Prevention of exercise-induced bronchoconstriction in children 6 to 14 years.Population: Children 6-14 yearsDailyMed (U.S. National Library of Medicine)
• Relief of allergic rhinitis symptoms when alternative therapies are inadequate or not tolerated.Population: Children 6-14 yearsDailyMed (U.S. National Library of Medicine)

• Most common (5% or more and above placebo): upper respiratory infection, fever, headache, pharyngitis, cough, abdominal pain, diarrhoea, otitis media, influenza, rhinorrhoea, sinusitis.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any component of the product.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: serious neuropsychiatric events (agitation, aggression, depression, sleep disturbances, suicidal thoughts and behaviour); weigh benefits and risks and reserve for allergic rhinitis with inadequate response to alternatives.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not for acute asthma attacks; do not abruptly substitute for corticosteroids; aspirin-sensitive patients should continue to avoid aspirin/NSAIDs; systemic eosinophilia/Churg-Strauss-type vasculitis reported.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• SINGULAIR chewable tablets contain aspartame (each 5 mg chewable tablet provides 0.842 mg phenylalanine; relevant in phenylketonuria); relevance to the Egyptian chewable tablet depends on its excipients, which were not verified.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Cohort studies over decades have not established a drug-associated risk of major birth defects; no adverse developmental effects in animals at high exposures.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Montelukast is present in human milk; available data do not suggest a significant risk to the breastfed infant.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Montelukast: Selective oral antagonist of the cysteinyl leukotriene type-1 (CysLT1) receptor.